EMEA (Europe, Middle East and Africa) Preventable Vaccines Market Report 2017

November 2017 | 125 pages | ID: EDB0FFA0A6DEN
QYResearch

Abstracts

In this report, the EMEA Preventable Vaccines market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Units), revenue (Million USD), market share and growth rate of Preventable Vaccines for these regions, from 2012 to 2022 (forecast)

• Europe: Germany, France, UK, Russia, Italy and Benelux;
• Middle East: Saudi Arabia, Israel, UAE and Iran;
• Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Preventable Vaccines market competition by top manufacturers/players, with Preventable Vaccines sales volume (K Units), price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including

• GlaxoSmithKline
• Merck
• Novartis
• Pfizer
• Sanofi
• Takeda Pharmaceutical
• Abbott
• Roche
• AstraZeneca
• Mitsubishi Tanabe Pharma
• Lupin
• Serum Institute of India
• LG Life Sciences
• S K Chemicals
• Shenzhen Kangtai Biological Products
• Sinovac Biotech
• Janssen Pharmaceuticals
• Crucell
• Bavarian Nordic
• Baxter
• Bharat Biotech
• Dynavax
• Valeant Pharmaceuticals
• Protein Sciences
• Panacea Biotec

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into

• Adult Preventable Vaccines
• Pediatric Preventable Vaccines

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Bacterial Diseases
• Virus Diseases

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

EMEA (Europe, Middle East and Africa) Preventable Vaccines Market Report 2017

1 PREVENTABLE VACCINES OVERVIEW

1.1 Product Overview and Scope of Preventable Vaccines
1.2 Classification of Preventable Vaccines
  1.2.1 EMEA Preventable Vaccines Market Size (Sales) Comparison by Type (2012-2022)
  1.2.2 EMEA Preventable Vaccines Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 Adult Preventable Vaccines
  1.2.4 Pediatric Preventable Vaccines
1.3 EMEA Preventable Vaccines Market by Application/End Users
  1.3.1 EMEA Preventable Vaccines Sales (Volume) and Market Share Comparison by Application (2012-2022
  1.3.2 Bacterial Diseases
  1.3.3 Virus Diseases
1.4 EMEA Preventable Vaccines Market by Region
  1.4.1 EMEA Preventable Vaccines Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 Europe Status and Prospect (2012-2022)
  1.4.3 Middle East Status and Prospect (2012-2022)
  1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of Preventable Vaccines (2012-2022)
  1.5.1 EMEA Preventable Vaccines Sales and Growth Rate (2012-2022)
  1.5.2 EMEA Preventable Vaccines Revenue and Growth Rate (2012-2022)

2 EMEA PREVENTABLE VACCINES COMPETITION BY MANUFACTURERS/PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 EMEA Preventable Vaccines Market Competition by Players/Manufacturers
  2.1.1 EMEA Preventable Vaccines Sales Volume and Market Share of Major Players (2012-2017)
  2.1.2 EMEA Preventable Vaccines Revenue and Share by Players (2012-2017)
  2.1.3 EMEA Preventable Vaccines Sale Price by Players (2012-2017)
2.2 EMEA Preventable Vaccines (Volume and Value) by Type/Product Category
  2.2.1 EMEA Preventable Vaccines Sales and Market Share by Type (2012-2017)
  2.2.2 EMEA Preventable Vaccines Revenue and Market Share by Type (2012-2017)
  2.2.3 EMEA Preventable Vaccines Sale Price by Type (2012-2017)
2.3 EMEA Preventable Vaccines (Volume) by Application
2.4 EMEA Preventable Vaccines (Volume and Value) by Region
  2.4.1 EMEA Preventable Vaccines Sales and Market Share by Region (2012-2017)
  2.4.2 EMEA Preventable Vaccines Revenue and Market Share by Region (2012-2017)
  2.4.3 EMEA Preventable Vaccines Sales Price by Region (2012-2017)

3 EUROPE PREVENTABLE VACCINES (VOLUME, VALUE AND SALES PRICE), BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

3.1 Europe Preventable Vaccines Sales and Value (2012-2017)
  3.1.1 Europe Preventable Vaccines Sales Volume and Growth Rate (2012-2017)
  3.1.2 Europe Preventable Vaccines Revenue and Growth Rate (2012-2017)
3.2 Europe Preventable Vaccines Sales and Market Share by Type
3.3 Europe Preventable Vaccines Sales and Market Share by Application
3.4 Europe Preventable Vaccines Sales Volume and Value (Revenue) by Countries
  3.4.1 Europe Preventable Vaccines Sales Volume by Countries (2012-2017)
  3.4.2 Europe Preventable Vaccines Revenue by Countries (2012-2017)
  3.4.3 Germany Preventable Vaccines Sales and Growth Rate (2012-2017)
  3.4.4 France Preventable Vaccines Sales and Growth Rate (2012-2017)
  3.4.5 UK Preventable Vaccines Sales and Growth Rate (2012-2017)
  3.4.6 Russia Preventable Vaccines Sales and Growth Rate (2012-2017)
  3.4.7 Italy Preventable Vaccines Sales and Growth Rate (2012-2017)
  3.4.8 Benelux Preventable Vaccines Sales and Growth Rate (2012-2017)

4 MIDDLE EAST PREVENTABLE VACCINES (VOLUME, VALUE AND SALES PRICE), BY REGION, TYPE AND APPLICATION

4.1 Middle East Preventable Vaccines Sales and Value (2012-2017)
  4.1.1 Middle East Preventable Vaccines Sales Volume and Growth Rate (2012-2017)
  4.1.2 Middle East Preventable Vaccines Revenue and Growth Rate (2012-2017)
4.2 Middle East Preventable Vaccines Sales and Market Share by Type
4.3 Middle East Preventable Vaccines Sales and Market Share by Application
4.4 Middle East Preventable Vaccines Sales Volume and Value (Revenue) by Countries
  4.4.1 Middle East Preventable Vaccines Sales Volume by Countries (2012-2017)
  4.4.2 Middle East Preventable Vaccines Revenue by Countries (2012-2017)
  4.4.3 Saudi Arabia Preventable Vaccines Sales and Growth Rate (2012-2017)
  4.4.4 Israel Preventable Vaccines Sales and Growth Rate (2012-2017)
  4.4.5 UAE Preventable Vaccines Sales and Growth Rate (2012-2017)
  4.4.6 Iran Preventable Vaccines Sales and Growth Rate (2012-2017)

5 AFRICA PREVENTABLE VACCINES (VOLUME, VALUE AND SALES PRICE) BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

5.1 Africa Preventable Vaccines Sales and Value (2012-2017)
  5.1.1 Africa Preventable Vaccines Sales Volume and Growth Rate (2012-2017)
  5.1.2 Africa Preventable Vaccines Revenue and Growth Rate (2012-2017)
5.2 Africa Preventable Vaccines Sales and Market Share by Type
5.3 Africa Preventable Vaccines Sales and Market Share by Application
5.4 Africa Preventable Vaccines Sales Volume and Value (Revenue) by Countries
  5.4.1 Africa Preventable Vaccines Sales Volume by Countries (2012-2017)
  5.4.2 Africa Preventable Vaccines Revenue by Countries (2012-2017)
  5.4.3 South Africa Preventable Vaccines Sales and Growth Rate (2012-2017)
  5.4.4 Nigeria Preventable Vaccines Sales and Growth Rate (2012-2017)
  5.4.5 Egypt Preventable Vaccines Sales and Growth Rate (2012-2017)
  5.4.6 Algeria Preventable Vaccines Sales and Growth Rate (2012-2017)

6 EMEA PREVENTABLE VACCINES MANUFACTURERS/PLAYERS PROFILES AND SALES DATA

6.1 GlaxoSmithKline
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Preventable Vaccines Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 GlaxoSmithKline Preventable Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Merck
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Preventable Vaccines Product Type, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Merck Preventable Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Novartis
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Preventable Vaccines Product Type, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Novartis Preventable Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Pfizer
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Preventable Vaccines Product Type, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Pfizer Preventable Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Sanofi
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Preventable Vaccines Product Type, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Sanofi Preventable Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Takeda Pharmaceutical
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Preventable Vaccines Product Type, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Takeda Pharmaceutical Preventable Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Abbott
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Preventable Vaccines Product Type, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Abbott Preventable Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Roche
  6.8.1 Company Basic Information, Manufacturing Base and Competitors
  6.8.2 Preventable Vaccines Product Type, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Roche Preventable Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 AstraZeneca
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 Preventable Vaccines Product Type, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 AstraZeneca Preventable Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 Mitsubishi Tanabe Pharma
  6.10.1 Company Basic Information, Manufacturing Base and Competitors
  6.10.2 Preventable Vaccines Product Type, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Mitsubishi Tanabe Pharma Preventable Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview
6.11 Lupin
6.12 Serum Institute of India
6.13 LG Life Sciences
6.14 S K Chemicals
6.15 Shenzhen Kangtai Biological Products
6.16 Sinovac Biotech
6.17 Janssen Pharmaceuticals
6.18 Crucell
6.19 Bavarian Nordic
6.20 Baxter
6.21 Bharat Biotech
6.22 Dynavax
6.23 Valeant Pharmaceuticals
6.24 Protein Sciences
6.25 Panacea Biotec

7 PREVENTABLE VACCINES MANUFACTURING COST ANALYSIS

7.1 Preventable Vaccines Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Preventable Vaccines

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Preventable Vaccines Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Preventable Vaccines Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA PREVENTABLE VACCINES MARKET FORECAST (2017-2022)

11.1 EMEA Preventable Vaccines Sales, Revenue and Price Forecast (2017-2022)
  11.1.1 EMEA Preventable Vaccines Sales and Growth Rate Forecast (2017-2022)
  11.1.2 EMEA Preventable Vaccines Revenue and Growth Rate Forecast (2017-2022)
  11.1.3 EMEA Preventable Vaccines Price and Trend Forecast (2017-2022)
11.2 EMEA Preventable Vaccines Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.3 Europe Preventable Vaccines Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.4 Middle Eastt Preventable Vaccines Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.5 Africa Preventable Vaccines Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.6 EMEA Preventable Vaccines Sales Forecast by Type (2017-2022)
11.7 EMEA Preventable Vaccines Sales Forecast by Application (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Preventable Vaccines
Figure EMEA Preventable Vaccines Sales Volume (K Units) by Type (2012-2022)
Figure EMEA Preventable Vaccines Sales Volume Market Share by Type (Product Category) in 2016
Figure Adult Preventable Vaccines Product Picture
Figure Pediatric Preventable Vaccines Product Picture
Figure EMEA Preventable Vaccines Sales Volume (K Units) by Application (2012-2022)
Figure EMEA Sales Market Share of Preventable Vaccines by Application in 2016
Figure Bacterial Diseases Examples
Table Key Downstream Customer in Bacterial Diseases
Figure Virus Diseases Examples
Table Key Downstream Customer in Virus Diseases
Figure EMEA Preventable Vaccines Market Size (Million USD) by Region (2012-2022)
Figure Europe Preventable Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Preventable Vaccines Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Preventable Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East Preventable Vaccines Revenue (Million USD) Status and Forecast by Countries
Figure Africa Preventable Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa Preventable Vaccines Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Preventable Vaccines Sales Volume and Growth Rate (2012-2022)
Figure EMEA Preventable Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA Preventable Vaccines Market Major Players Product Sales Volume (K Units) (2012-2017)
Table EMEA Preventable Vaccines Sales Volume (K Units) of Major Players (2012-2017)
Table EMEA Preventable Vaccines Sales Share by Players (2012-2017)
Figure 2016 Preventable Vaccines Sales Share by Players
Figure 2017 Preventable Vaccines Sales Share by Players
Figure EMEA Preventable Vaccines Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA Preventable Vaccines Revenue (Million USD) by Players (2012-2017)
Table EMEA Preventable Vaccines Revenue Share by Players (2012-2017)
Table 2016 EMEA Preventable Vaccines Revenue Share by Players
Table 2017 EMEA Preventable Vaccines Revenue Share by Players
Table EMEA Preventable Vaccines Sale Price (USD/Unit) by Players (2012-2017)
Table EMEA Preventable Vaccines Sales (K Units) and Market Share by Type (2012-2017)
Table EMEA Preventable Vaccines Sales Share by Type (2012-2017)
Figure Sales Market Share of Preventable Vaccines by Type (2012-2017)
Figure EMEA Preventable Vaccines Sales Market Share by Type (2012-2017)
Table EMEA Preventable Vaccines Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA Preventable Vaccines Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Preventable Vaccines by Type in 2016
Table EMEA Preventable Vaccines Sale Price (USD/Unit) by Type (2012-2017)
Table EMEA Preventable Vaccines Sales (K Units) and Market Share by Application (2012-2017)
Table EMEA Preventable Vaccines Sales Share by Application (2012-2017)
Figure Sales Market Share of Preventable Vaccines by Application (2012-2017)
Figure EMEA Preventable Vaccines Sales Market Share by Application in 2016
Table EMEA Preventable Vaccines Sales (K Units) and Market Share by Region (2012-2017)
Table EMEA Preventable Vaccines Sales Share by Region (2012-2017)
Figure Sales Market Share of Preventable Vaccines by Region (2012-2017)
Figure EMEA Preventable Vaccines Sales Market Share in 2016
Table EMEA Preventable Vaccines Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA Preventable Vaccines Revenue Share by Region (2012-2017)
Figure Revenue Market Share of Preventable Vaccines by Region (2012-2017)
Figure EMEA Preventable Vaccines Revenue Market Share Regions in 2016
Table EMEA Preventable Vaccines Sales Price (USD/Unit) by Region (2012-2017)
Figure Europe Preventable Vaccines Sales (K Units) and Growth Rate (2012-2017)
Figure Europe Preventable Vaccines Revenue and Growth Rate (2012-2017)
Table Europe Preventable Vaccines Sales (K Units) by Type (2012-2017)
Table Europe Preventable Vaccines Market Share by Type (2012-2017)
Figure Europe Preventable Vaccines Market Share by Type in 2016
Table Europe Preventable Vaccines Sales (K Units) by Application (2012-2017)
Table Europe Preventable Vaccines Market Share by Application (2012-2017)
Figure Europe Preventable Vaccines Market Share by Application in 2016
Table Europe Preventable Vaccines Sales (K Units) by Countries (2012-2017)
Table Europe Preventable Vaccines Sales Market Share by Countries (2012-2017)
Figure Europe Preventable Vaccines Sales Market Share by Countries (2012-2017)
Figure Europe Preventable Vaccines Sales Market Share by Countries in 2016
Table Europe Preventable Vaccines Revenue (Million USD) by Countries (2012-2017)
Table Europe Preventable Vaccines Revenue Market Share by Countries (2012-2017)
Figure Europe Preventable Vaccines Revenue Market Share by Countries (2012-2017)
Figure Europe Preventable Vaccines Revenue Market Share by Countries in 2016
Figure Germany Preventable Vaccines Sales (K Units) and Growth Rate (2012-2017)
Figure France Preventable Vaccines Sales (K Units) and Growth Rate (2012-2017)
Figure UK Preventable Vaccines Sales (K Units) and Growth Rate (2012-2017)
Figure Russia Preventable Vaccines Sales (K Units) and Growth Rate (2012-2017)
Figure Italy Preventable Vaccines Sales (K Units) and Growth Rate (2012-2017)
Figure Benelux Preventable Vaccines Sales (K Units) and Growth Rate (2012-2017)
Figure Middle East Preventable Vaccines Sales (K Units) and Growth Rate (2012-2017)
Figure Middle East Preventable Vaccines Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East Preventable Vaccines Sales (K Units) by Type (2012-2017)
Table Middle East Preventable Vaccines Market Share by Type (2012-2017)
Figure Middle East Preventable Vaccines Market Share by Type (2012-2017)
Table Middle East Preventable Vaccines Sales (K Units) by Applications (2012-2017)
Table Middle East Preventable Vaccines Market Share by Applications (2012-2017)
Figure Middle East Preventable Vaccines Sales Market Share by Application in 2016
Table Middle East Preventable Vaccines Sales Volume (K Units) by Countries (2012-2017)
Table Middle East Preventable Vaccines Sales Volume Market Share by Countries (2012-2017)
Figure Middle East Preventable Vaccines Sales Volume Market Share by Countries in 2016
Table Middle East Preventable Vaccines Revenue (Million USD) by Countries (2012-2017)
Table Middle East Preventable Vaccines Revenue Market Share by Countries (2012-2017)
Figure Middle East Preventable Vaccines Revenue Market Share by Countries (2012-2017)
Figure Middle East Preventable Vaccines Revenue Market Share by Countries in 2016
Figure Saudi Arabia Preventable Vaccines Sales (K Units) and Growth Rate (2012-2017)
Figure Israel Preventable Vaccines Sales (K Units) and Growth Rate (2012-2017)
Figure UAE Preventable Vaccines Sales (K Units) and Growth Rate (2012-2017)
Figure Iran Preventable Vaccines Sales (K Units) and Growth Rate (2012-2017)
Figure Africa Preventable Vaccines Sales (K Units) and Growth Rate (2012-2017)
Figure Africa Preventable Vaccines Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa Preventable Vaccines Sales (K Units) by Type (2012-2017)
Table Africa Preventable Vaccines Sales Market Share by Type (2012-2017)
Figure Africa Preventable Vaccines Sales Market Share by Type (2012-2017)
Figure Africa Preventable Vaccines Sales Market Share by Type in 2016
Table Africa Preventable Vaccines Sales (K Units) by Application (2012-2017)
Table Africa Preventable Vaccines Sales Market Share by Application (2012-2017)
Figure Africa Preventable Vaccines Sales Market Share by Application (2012-2017)
Table Africa Preventable Vaccines Sales Volume (K Units) by Countries (2012-2017)
Table Africa Preventable Vaccines Sales Market Share by Countries (2012-2017)
Figure Africa Preventable Vaccines Sales Market Share by Countries (2012-2017)
Figure Africa Preventable Vaccines Sales Market Share by Countries in 2016
Table Africa Preventable Vaccines Revenue (Million USD) by Countries (2012-2017)
Table Africa Preventable Vaccines Revenue Market Share by Countries (2012-2017)
Figure Africa Preventable Vaccines Revenue Market Share by Countries (2012-2017)
Figure Africa Preventable Vaccines Revenue Market Share by Countries in 2016
Figure South Africa Preventable Vaccines Sales (K Units) and Growth Rate (2012-2017)
Figure Nigeria Preventable Vaccines Sales (K Units) and Growth Rate (2012-2017)
Figure Egypt Preventable Vaccines Sales (K Units) and Growth Rate (2012-2017)
Figure Algeria Preventable Vaccines Sales (K Units) and Growth Rate (2012-2017)
Table GlaxoSmithKline Preventable Vaccines Basic Information List
Table GlaxoSmithKline Preventable Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure GlaxoSmithKline Preventable Vaccines Sales (K Units) and Growth Rate (2012-2017)
Figure GlaxoSmithKline Preventable Vaccines Sales Market Share in EMEA (2012-2017)
Figure GlaxoSmithKline Preventable Vaccines Revenue Market Share in EMEA (2012-2017)
Table Merck Preventable Vaccines Basic Information List
Table Merck Preventable Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Merck Preventable Vaccines Sales (K Units) and Growth Rate (2012-2017)
Figure Merck Preventable Vaccines Sales Market Share in EMEA (2012-2017)
Figure Merck Preventable Vaccines Revenue Market Share in EMEA (2012-2017)
Table Novartis Preventable Vaccines Basic Information List
Table Novartis Preventable Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Novartis Preventable Vaccines Sales (K Units) and Growth Rate (2012-2017)
Figure Novartis Preventable Vaccines Sales Market Share in EMEA (2012-2017)
Figure Novartis Preventable Vaccines Revenue Market Share in EMEA (2012-2017)
Table Pfizer Preventable Vaccines Basic Information List
Table Pfizer Preventable Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Pfizer Preventable Vaccines Sales (K Units) and Growth Rate (2012-2017)
Figure Pfizer Preventable Vaccines Sales Market Share in EMEA (2012-2017)
Figure Pfizer Preventable Vaccines Revenue Market Share in EMEA (2012-2017)
Table Sanofi Preventable Vaccines Basic Information List
Table Sanofi Preventable Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Sanofi Preventable Vaccines Sales (K Units) and Growth Rate (2012-2017)
Figure Sanofi Preventable Vaccines Sales Market Share in EMEA (2012-2017)
Figure Sanofi Preventable Vaccines Revenue Market Share in EMEA (2012-2017)
Table Takeda Pharmaceutical Preventable Vaccines Basic Information List
Table Takeda Pharmaceutical Preventable Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Takeda Pharmaceutical Preventable Vaccines Sales (K Units) and Growth Rate (2012-2017)
Figure Takeda Pharmaceutical Preventable Vaccines Sales Market Share in EMEA (2012-2017)
Figure Takeda Pharmaceutical Preventable Vaccines Revenue Market Share in EMEA (2012-2017)
Table Abbott Preventable Vaccines Basic Information List
Table Abbott Preventable Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Abbott Preventable Vaccines Sales (K Units) and Growth Rate (2012-2017)
Figure Abbott Preventable Vaccines Sales Market Share in EMEA (2012-2017)
Figure Abbott Preventable Vaccines Revenue Market Share in EMEA (2012-2017)
Table Roche Preventable Vaccines Basic Information List
Table Roche Preventable Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Roche Preventable Vaccines Sales (K Units) and Growth Rate (2012-2017)
Figure Roche Preventable Vaccines Sales Market Share in EMEA (2012-2017)
Figure Roche Preventable Vaccines Revenue Market Share in EMEA (2012-2017)
Table AstraZeneca Preventable Vaccines Basic Information List
Table AstraZeneca Preventable Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure AstraZeneca Preventable Vaccines Sales (K Units) and Growth Rate (2012-2017)
Figure AstraZeneca Preventable Vaccines Sales Market Share in EMEA (2012-2017)
Figure AstraZeneca Preventable Vaccines Revenue Market Share in EMEA (2012-2017)
Table Mitsubishi Tanabe Pharma Preventable Vaccines Basic Information List
Table Mitsubishi Tanabe Pharma Preventable Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Mitsubishi Tanabe Pharma Preventable Vaccines Sales (K Units) and Growth Rate (2012-2017)
Figure Mitsubishi Tanabe Pharma Preventable Vaccines Sales Market Share in EMEA (2012-2017)
Figure Mitsubishi Tanabe Pharma Preventable Vaccines Revenue Market Share in EMEA (2012-2017)
Table Lupin Preventable Vaccines Basic Information List
Table Serum Institute of India Preventable Vaccines Basic Information List
Table LG Life Sciences Preventable Vaccines Basic Information List
Table S K Chemicals Preventable Vaccines Basic Information List
Table Shenzhen Kangtai Biological Products Preventable Vaccines Basic Information List
Table Sinovac Biotech Preventable Vaccines Basic Information List
Table Janssen Pharmaceuticals Preventable Vaccines Basic Information List
Table Crucell Preventable Vaccines Basic Information List
Table Bavarian Nordic Preventable Vaccines Basic Information List
Table Baxter Preventable Vaccines Basic Information List
Table Bharat Biotech Preventable Vaccines Basic Information List
Table Dynavax Preventable Vaccines Basic Information List
Table Valeant Pharmaceuticals Preventable Vaccines Basic Information List
Table Protein Sciences Preventable Vaccines Basic Information List
Table Panacea Biotec Preventable Vaccines Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Preventable Vaccines
Figure Manufacturing Process Analysis of Preventable Vaccines
Figure Preventable Vaccines Industrial Chain Analysis
Table Raw Materials Sources of Preventable Vaccines Major Manufacturers in 2016
Table Major Buyers of Preventable Vaccines
Table Distributors/Traders List
Figure EMEA Preventable Vaccines Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure EMEA Preventable Vaccines Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA Preventable Vaccines Price (USD/Unit) and Trend Forecast (2017-2022)
Table EMEA Preventable Vaccines Sales (K Units) Forecast by Region (2017-2022)
Figure EMEA Preventable Vaccines Sales Market Share Forecast by Region (2017-2022)
Table EMEA Preventable Vaccines Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA Preventable Vaccines Revenue Market Share Forecast by Region (2017-2022)
Table Europe Preventable Vaccines Sales (K Units) Forecast by Countries (2017-2022)
Figure Europe Preventable Vaccines Sales Market Share Forecast by Countries (2017-2022)
Table Europe Preventable Vaccines Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe Preventable Vaccines Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East Preventable Vaccines Sales (K Units) Forecast by Countries (2017-2022)
Figure Middle East Preventable Vaccines Sales Market Share Forecast by Countries (2017-2022)
Table Middle East Preventable Vaccines Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East Preventable Vaccines Revenue Market Share Forecast by Countries (2017-2022)
Table Africa Preventable Vaccines Sales (K Units) Forecast by Countries (2017-2022)
Figure Africa Preventable Vaccines Sales Market Share Forecast by Countries (2017-2022)
Table Africa Preventable Vaccines Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa Preventable Vaccines Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA Preventable Vaccines Sales (K Units) Forecast by Type (2017-2022)
Figure EMEA Preventable Vaccines Sales Market Share Forecast by Type (2017-2022)
Table EMEA Preventable Vaccines Sales (K Units) Forecast by Application (2017-2022)
Figure EMEA Preventable Vaccines Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources